Skip to main content
Fig. 5 | BMC Medical Imaging

Fig. 5

From: [18F]FDG PET/CT in head and neck squamous cell carcinoma: a head-to-head between visual point-scales and the added value of multi-modality imaging

Fig. 5

♂, 53yo. with poorly differentiated squamous carcinoma of the posterior tongue histologically proven. Baseline PET/CT showed a pathological FDG-uptake in the primary tumor site as well as in the right cervical and supraclavicular lymph nodes. End-of-treatment (EOT) PET/CT, performed 14 weeks after radiotherapy, showed moderate residual uptake near the primary tumor site first considered as treatment-related and scores undetermined in 2 out of 3 visual scores. However, the follow-up PET/CT, performed about 10 months after EOT, showed a relapse of the disease in the primary tumor site as well as a contralateral lymph node spread

Back to article page